ARLINGTON, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered direct offering priced at ...
ARLINGTON, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...
MENLO PARK, Calif. and ARLINGTON, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development ...
KALA BIO Inc. Annual stock financials by MarketWatch. View the latest KALA financial statements, income statements and financial ratios.
The latest update is out from KALA BIO ( (KALA)). KALA BIO has scheduled its next annual meeting of stockholders for January 30, 2026, with stockholder proposals due by December 27, 2025. The company ...
Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA) Toronto, ...
The latest update is out from KALA BIO ( (KALA)). On March 3, 2026, KALA BIO entered into a 12‑month Platform Development and Exclusive License Agreement with Younet AI, securing a worldwide exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results